Expression of vascular endothelial growth factor receptor-3 in the endometrium in menorrhagia

International Journal of Molecular Medicine

Volumn 19, Issue 6, 2007, Pages 909-913

  Mints, Miriam ^a   Blomgren, Bo ^b   Palmblad, Jan ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b ASTRAZENECA R AND D   (Sweden)

Author keywords

Angiogenesis; Endometrium; Menorrhagia; Vascular endothelial growth factor receptor 3

Indexed keywords

VASCULOTROPIN RECEPTOR 3;

ADULT; ARTICLE; BLOOD VESSEL; CASE CONTROL STUDY; COMPARATIVE STUDY; ENDOMETRIUM; FEMALE; GENE EXPRESSION; HUMAN; MENORRHAGIA; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PHYSIOLOGY; VASCULARIZATION;

ADULT; BLOOD VESSELS; CASE-CONTROL STUDIES; ENDOMETRIUM; FEMALE; GENE EXPRESSION; HUMANS; MENORRHAGIA; NEOVASCULARIZATION, PATHOLOGIC; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-3;

EID: 34548598261     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.19.6.909     Document Type: Article

References (14)

1. Hallberg L, Hogdahl AM, Nilsson L and Rybo G: Menstrual blood loss - a population study. Variation at different ages and attempts to define normality. Acta Obstet Gynecol Scand 45: 320-351, 1966.
2. Smith SK: Angiogenesis and reproduction. Br J Obstet Gynaecol 108: 777-783, 2001.
3. Ferrara N, Gerber HP and LeCouter J: The biology of VEGF and its receptors. Nat Med 9: 669-676, 2003.
4. Witmer AN, van Blijswijk BC, Dai J, Hofman P, Partanen TA, Vrensen GF, et al: VEGFR-3 in adult angiogenesis. J Pathol 195: 490-497, 2001.
5. Mints M, Blomgren B, Falconer C, Fianu-Jonasson A and Palmblad J: Microvascular density, vascular endothelial growth factor A, and its receptors in endometrial blood vessels in patients with menorrhagia. Fertil Steril 84: 692-700, 2005.
6. Achen MG, Jeltsch M, Kukk E, Makinen T, Vitali A, Wilks AF, et al: Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4). Proc Natl Acad Sci USA 95: 548-553, 1998.
7. Mints M, Blomgren B, Falconer C and Palmblad J: Expression of the vascular endothelial growth factor (VEGF) family in human endometrial blood vessels. Scand J Clin Lab Invest 62: 167-175, 2002.
8. Gundersen HJ, Bendtsen TF, Korbo L, Marcussen N, Moller A, Nielsen K, et al: Some new, simple and efficient stereological methods and their use in pathological research and diagnosis. APMIS 96: 379-394, 1988.
9. Partanen TA, Arola J, Saaristo A, Jussila L, Ora A, Miettinen M, et al: VEGF-C and VEGF-D expression in neuroendocrine cells and their receptor, VEGFR-3, in fenestrated blood vessels in human tissues. FASEB J 14: 2087-2096, 2000.
10. Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ and Holash J: Vascular-specific growth factors and blood vessel formation. Nature 407: 242-248, 2000.
11. Li XF, Charnock-Jones DS, Zhang E, Hiby S, Malik S, Day K, et al: Angiogenic growth factor messenger ribonucleic acids in uterine natural killer cells. J Clin Endocrinol Metab 86: 1823-1834, 2001.
12. Yokoyama Y, Charnock-Jones DS, Licence D, Yanaihara A, Hastings JM, Holland CM, et al: Expression of vascular endothelial growth factor (VEGF)-D and its receptor, VEGF receptor 3, as a prognostic factor in endometrial carcinoma. Clin Cancer Res 9: 1361-1369, 2003.
13. Kubo H, Fujiwara T, Jussila L, Hashi H, Ogawa M, Shimizu K, et al: Involvement of vascular endothelial growth factor receptor-3 in maintenance of integrity of endothelial cell lining during tumor angiogenesis. Blood 96: 546-553, 2000.
14. Nilsson I, Rolny C, Wu Y, Pytowski B, Hicklin D, Alitalo K, et al: Vascular endothelial growth factor receptor-3 in hypoxia-induced vascular development. FASEB J 18: 1507-1515, 2004. (Pubitemid 39336632)